Portage Biotech (PRTG) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free PRTG Stock Alerts $0.24 -0.01 (-4.05%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePortage Biotech halts trial enrollment, seeks strategic optionsinvesting.com - April 14 at 12:51 AMPortage Down on Announcing Alternativesmsn.com - April 12 at 6:55 PMPortage Biotech Announces Plans to Expand its Evaluation of Strategic Alternativesglobenewswire.com - April 12 at 8:01 AMPortage Biotech Completes Monetization of Intensity Therapeutics (INTS) sharesglobenewswire.com - March 26 at 8:01 AMPRTG: Extending the Runwayfinance.yahoo.com - March 11 at 12:41 PMPortage Biotech Inc PRTGmorningstar.com - March 3 at 2:23 PMPortage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Updateglobenewswire.com - February 28 at 5:10 PMH.C. Wainwright downgrades Portage Biotech on financing overhangrealmoney.thestreet.com - January 8 at 11:59 PMPortage Biotech just downgraded at H.C. Wainwright, here's whyrealmoney.thestreet.com - January 8 at 11:59 PMPRTG: Bridging I-O: Working in Harmony with Checkpointsfinance.yahoo.com - January 8 at 1:58 PMPortage Biotech Shares Fall 6% on Job Reductions, Paused Drug Development Programmarketwatch.com - January 4 at 12:37 PMPortage Biotech To Pause INKT Clinical Development; To Evaluate Potential Strategic Optionsmarkets.businessinsider.com - January 4 at 12:37 PMPortage Biotech to halt iNKT drug program, cut workforcemsn.com - January 4 at 12:37 PMPortage Biotech Reports Business and Strategic Updatefinance.yahoo.com - January 4 at 12:37 PMPortage Biotech GAAP EPS of -$0.29msn.com - November 28 at 11:24 PMPortage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Updatefinance.yahoo.com - November 28 at 6:24 PMPortage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meetingbenzinga.com - November 6 at 8:54 AMPortage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer’s (SITC) 38th Annual Meetingfinance.yahoo.com - November 6 at 8:54 AMPortage Biotech files to sell 9.63M shares for holdersmsn.com - October 31 at 6:57 PMPortage Biotech Announces $6.0 Million Registered Direct Offeringfinance.yahoo.com - September 29 at 9:31 AMPortage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conferencefinance.yahoo.com - September 20 at 9:29 AMAnalyst Expectations for Portage Biotech's Futuremarkets.businessinsider.com - September 7 at 4:45 PMPortage Biotech in Keytruda Collaboration With Merckmarketwatch.com - September 5 at 8:27 AMPortage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagonists in Combination with KEYTRUDA® (Pembrolizumab) in Solid Tumorsfinance.yahoo.com - September 5 at 8:27 AMCantor Fitzgerald Reiterates Portage Biotech (PRTG) Overweight Recommendationmsn.com - September 1 at 9:05 PMPortage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Updatefinance.yahoo.com - August 30 at 3:15 PMHC Wainwright & Co. Maintains Portage Biotech (PRTG) Buy Recommendationmsn.com - August 2 at 11:08 PMPortage Biotech Inc (PRTG) Receives a Buy from H.C. Wainwrightmarkets.businessinsider.com - August 2 at 10:32 AMUniversity Hospitals Portage Medical Centerhealth.usnews.com - August 2 at 12:32 AMCantor Fitzgerald Maintains Portage Biotech (PRTG) Overweight Recommendationmsn.com - August 1 at 7:31 PMPortage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results and Business Updatefinance.yahoo.com - July 31 at 6:05 PMPortage Biotech Announces First Patient Dosed in Phase 1a Trial of PORT-6 in Select Solid Tumorsfinance.yahoo.com - June 26 at 9:26 AMWhy Portage Biotech Stock Is Up Todaybenzinga.com - June 5 at 4:24 PMPortage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meetingfinance.yahoo.com - June 5 at 10:57 AMmarketbeat.com - June 5 at 9:51 AMPortage Biotech to Participate in Panel Discussion During the 2023 BIO International Conferencefinance.yahoo.com - June 1 at 9:40 AMPortage Central High Schoolusnews.com - April 29 at 1:51 PMPortage Biotech Announces Upcoming PORT-2 Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meetingfinance.yahoo.com - April 26 at 9:02 PMPortage High Schoolusnews.com - April 19 at 8:48 PMTrack Covid-19 in Portage County, Wisconsinnytimes.com - April 12 at 1:54 PMPortage Biotech Stock (NASDAQ:PRTG), Dividendsbenzinga.com - March 12 at 5:52 PMPortage Biotech to Present at Oppenheimer’s 33rd Annual Healthcare Conferencefinance.yahoo.com - March 7 at 8:50 AMPortage Biotech Announces Results for Fiscal Quarter Ended December 31, 2022finance.yahoo.com - March 1 at 9:55 AMPortage Biotech Hosting Key Opinion Leader Event on Targeting the Adenosine Pathway in Cancerfinance.yahoo.com - February 27 at 5:54 PMPortage Biotech reports FY resultsmsn.com - February 23 at 10:44 AMPortage Biotech to Participate in Citi's 2023 Virtual Oncology Leadership Summitfinance.yahoo.com - February 15 at 10:13 AMPRTG Portage Biotech Inc.seekingalpha.com - January 21 at 12:17 AMmarketbeat.com - December 29 at 10:59 AMQ3 2023 EPS Estimates for Portage Biotech Inc. (NASDAQ:PRTG) Raised by Analystmarketbeat.com - December 5 at 1:45 AMHow Much Upside is Left in Portage Biotech Inc. (PRTG)? Wall Street Analysts Think 160%nasdaq.com - December 2 at 7:21 PM Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address The “Next Bitcoin”? 10 CENT Crypto Set to Explode (Ad)The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon… Click For My #1 FREE Crypto for 2024 PRTG Media Mentions By Week PRTG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTG News Sentiment▼-1.000.38▲Average Medical News Sentiment PRTG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTG Articles This Week▼10▲PRTG Articles Average Week Get Portage Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Finch Therapeutics Group News Minerva Surgical News Soligenix News Palisade Bio News Bright Minds Biosciences News NanoString Technologies News Synaptogenix News Acutus Medical News LumiraDx News GT Biopharma News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTG) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsYour Money is Not SafeAmerican AlternativeFed launches fourth dollar overhaulStansberry ResearchThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Portage Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
